From the Desk of the AAGL President – Advisory Statement on Essure and AUGS Position Statement on Midurethral Slings
As many of you know, in the preceding months there have been communications from the FDA and numerous societal discussions as it relates to two very important surgical devices in our gynecologic armamentarium: the Essure for hysteroscopic sterilization and the mesh midurethral slings for stress urinary incontinence. This recent focus on two of our minimally invasive surgical treatments is consistent with the fact that the surgical healthcare landscape in gynecology has continued to come under fire over the last several years. Patient concerns, medico-legal targeting, and public misinformation have driven much of the scrutiny.
As a result, I would like to bring to your attention two very important documents. The first is our AAGL Advisory Statement on the Essure device. It was developed with the intent to provide an unbiased, evidence-based view of the critical aspects of hysteroscopic sterilization. The second is a joint position statement developed by AUGS and SUFU in order to justify the use of the mesh midurethral sling in the surgical management of stress urinary incontinence. This position statement, which outlines very nicely the safety and effectiveness of mesh midurethral slings, has been endorsed by the AAGL.
I hope that you refer to these two documents to stay informed about developments in minimally invasive gynecologic surgery. Through the sharing of information and collaborative support of other societies with similar goals of elevating gynecologic surgery, the proper narratives in healthcare can be written.
Arnold P. Advincula, MD
Filed under "Association News".